Paul Goode
Chief Executive Officer, Director · Glucotrack, Inc.
Individual
- 2025
- Mar 25, 2025
- 1
Filings (90d)
0
Other insiders active in the same sector
No other insider has filed at Paul Goode's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- James E. Flynn - $70.87M in NUVL purchases and sales in the last 12 months
- Joaquin Duato - $66.84M in JNJ purchases and sales in the last 12 months
- EcoR1 Capital, LLC - $65.00M in TRAX purchases and sales in the last 12 months
- Forbion Growth Opportunities Fund III Cooperatief U.A. - $64.80M in BRVE purchases and sales in the last 12 months
- RA CAPITAL MANAGEMENT, L.P. - $63.45M in SEPN purchases and sales in the last 12 months
- BVF PARTNERS L P - $62.96M in MLTX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Paul Goode?
Paul Goode is a corporate insider, tracked as Chief Executive Officer, Director of Glucotrack, Inc. (GCTK). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Paul Goode last file a Form 4?
The only primary Form 4 on record is dated 25 March 2025.
